<![CDATA[Sanofi SA]]>https://www.ft.com/stream/35509ea0-bccd-41f1-80e7-d4e83ece7dc0RSS for NodeMon, 02 Jun 2025 11:00:12 GMT15<![CDATA[Sanofi to buy US blood disorder drugmaker for up to $9.5bn]]>https://www.ft.com/content/27b78127-759c-4438-9a49-349b8b6f11ba27b78127-759c-4438-9a49-349b8b6f11baMon, 02 Jun 2025 08:35:56 GMT<![CDATA[Pharma bosses call for higher drug prices in EU to counter tariff threat]]>https://www.ft.com/content/8c66daf4-4b87-447b-b4f5-25fd6a3c37a28c66daf4-4b87-447b-b4f5-25fd6a3c37a2Wed, 23 Apr 2025 04:00:37 GMT<![CDATA[Vaccine stocks hit by RFK Jr nomination]]>https://www.ft.com/content/401e8947-bd02-4ac8-9fb2-eab01977eb4c401e8947-bd02-4ac8-9fb2-eab01977eb4cFri, 15 Nov 2024 17:22:20 GMT<![CDATA[Sanofi deal offers only partial headache relief]]>https://www.ft.com/content/79583e2e-f92a-4a7b-aac5-e80c4dd52c4079583e2e-f92a-4a7b-aac5-e80c4dd52c40Mon, 21 Oct 2024 14:59:10 GMT<![CDATA[France takes stake in Sanofi unit as part of €16bn sale to CD&R]]>https://www.ft.com/content/b83157a6-08c4-4dc1-a5f6-3f5ebafb42c4b83157a6-08c4-4dc1-a5f6-3f5ebafb42c4Mon, 21 Oct 2024 06:58:44 GMT<![CDATA[Sanofi joins rivals investing in nuclear cancer treatment]]>https://www.ft.com/content/7987aa5d-461f-4773-8455-4e021e3357dd7987aa5d-461f-4773-8455-4e021e3357ddThu, 17 Oct 2024 12:48:24 GMT<![CDATA[France warns it could block €15.5bn Sanofi consumer health deal]]>https://www.ft.com/content/9fc201f7-6416-4015-9eec-6c901ae4a67d9fc201f7-6416-4015-9eec-6c901ae4a67dTue, 15 Oct 2024 11:42:37 GMT<![CDATA[CD&R beats rivals in pursuit of €15.5bn Sanofi consumer health unit]]>https://www.ft.com/content/7f300ac9-8057-4766-8c46-e64fd04f38647f300ac9-8057-4766-8c46-e64fd04f3864Fri, 11 Oct 2024 14:21:00 GMT<![CDATA[Private equity puts the L back in LBO]]>https://www.ft.com/content/c9fc13f7-d69e-4e5b-89a1-fb0d33fc6858c9fc13f7-d69e-4e5b-89a1-fb0d33fc6858Tue, 01 Oct 2024 04:00:35 GMT<![CDATA[Sanofi pushes ahead with €20bn consumer healthcare spin-off]]>https://www.ft.com/content/455bf26e-1ad7-4f99-bdfb-11b696227fca455bf26e-1ad7-4f99-bdfb-11b696227fcaSun, 02 Jun 2024 04:00:26 GMT<![CDATA[Sanofi licensing deal doubles value of vaccine group Novavax]]>https://www.ft.com/content/09ca907f-f036-4e7e-b483-ca6ddac22cf509ca907f-f036-4e7e-b483-ca6ddac22cf5Fri, 10 May 2024 21:26:59 GMT<![CDATA[Diabetes drug offers hope to Parkinson’s sufferers]]>https://www.ft.com/content/f5da9cd1-b115-410a-93a6-24e6668e40f2f5da9cd1-b115-410a-93a6-24e6668e40f2Wed, 03 Apr 2024 21:04:01 GMT<![CDATA[Europe’s ‘Granolas’ fuel record stock market surge]]>https://www.ft.com/content/b87e7bd6-b2be-43ca-bf03-a221383a8a92b87e7bd6-b2be-43ca-bf03-a221383a8a92Fri, 23 Feb 2024 20:00:56 GMT<![CDATA[Sanofi: chief must prove he can win R&D game]]>https://www.ft.com/content/05fa7cf0-a1d6-4a5c-b9af-d10ab9ad23a105fa7cf0-a1d6-4a5c-b9af-d10ab9ad23a1Thu, 07 Dec 2023 14:59:41 GMT<![CDATA[Sanofi chief says he could have done a better job outlining R&D plan ]]>https://www.ft.com/content/685da21e-d098-4c0f-8d17-382e3225d118685da21e-d098-4c0f-8d17-382e3225d118Thu, 07 Dec 2023 02:30:04 GMT<![CDATA[French prosecutors examine claims of market manipulation against Sanofi]]>https://www.ft.com/content/11460824-9ba4-445f-9b54-c44467f269b211460824-9ba4-445f-9b54-c44467f269b2Tue, 07 Nov 2023 13:55:05 GMT<![CDATA[Sanofi shares fall 19% after cut to profit outlook]]>https://www.ft.com/content/6f12dad4-dc09-4bb5-b1c7-941eb2408bac6f12dad4-dc09-4bb5-b1c7-941eb2408bacFri, 27 Oct 2023 15:33:09 GMT<![CDATA[Sanofi/Provention: innovative diabetes drug is a good fit]]>https://www.ft.com/content/7b7ae52e-b365-43dc-ba9a-a5cc11e70cc37b7ae52e-b365-43dc-ba9a-a5cc11e70cc3Mon, 01 May 2023 13:00:56 GMT<![CDATA[UK at risk of losing healthcare innovation race with rivals, warns Sanofi boss]]>https://www.ft.com/content/62b72543-8160-48e6-90bd-68771afeb19b62b72543-8160-48e6-90bd-68771afeb19bFri, 03 Feb 2023 12:43:02 GMT<![CDATA[GSK and Sanofi shares surge after Zantac ruling victory ]]>https://www.ft.com/content/c52440c6-8309-4d60-810f-512b67cec89cc52440c6-8309-4d60-810f-512b67cec89cTue, 06 Dec 2022 22:03:26 GMT<![CDATA[Sanofi nominates SocGen boss Frédéric Oudéa as chair]]>https://www.ft.com/content/5d9445e6-0399-47bd-8f78-700c05e053d95d9445e6-0399-47bd-8f78-700c05e053d9Mon, 05 Sep 2022 08:56:24 GMT<![CDATA[Sanofi drops experimental breast cancer drug after second trial fails]]>https://www.ft.com/content/00147948-e698-41dd-ba38-fa06fafd348200147948-e698-41dd-ba38-fa06fafd3482Wed, 17 Aug 2022 16:39:13 GMT<![CDATA[Pharma groups lose £30bn of value on heartburn drug lawsuit worries]]>https://www.ft.com/content/6cb2bc93-fc61-4559-a876-2cf1b78fa7566cb2bc93-fc61-4559-a876-2cf1b78fa756Thu, 11 Aug 2022 21:01:02 GMT<![CDATA[Sanofi-GSK Covid vaccine found effective against Omicron]]>https://www.ft.com/content/fab58cc0-2382-4f5e-b287-041d4ad65141fab58cc0-2382-4f5e-b287-041d4ad65141Fri, 24 Jun 2022 07:15:06 GMT<![CDATA[Sanofi and GSK report ‘positive’ results from Covid booster]]>https://www.ft.com/content/8da80d74-9ba3-4e96-950f-d6501af39dd98da80d74-9ba3-4e96-950f-d6501af39dd9Mon, 13 Jun 2022 09:01:36 GMT